Evidence map›Paper›PMID 12595483›Full record

ArticleInfection and immunity2003

Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major.

Colby Zaph, Phillip Scott

Abstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Pathogen Evasion of Chemokine Response Through Suppression of CXCL10.Frontiers in cellular and infection microbiology · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Colby ZaphDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Phillip Scott

Funding

IL12 AS AN IMMUNOPOTENTIATOR IN LEISHMANIASISR01AI035914 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, PHILLIP · 1994 to 2013
$4.5M
IL-12 as an immunopotentiator in leishmaniasisR21AI035914 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, PHILLIP A. · 2002 to 2002
$396k
NIAID NIH HHS AI35914NIAID NIH HHS R01 AI035914NIAID NIH HHS R21 AI035914
6 · The paper itself

Abstract

Following infection with Leishmania major, the chemokines XCL1, CXCL10, and CCL2 were preferentially expressed in draining lymph nodes of resistant mice. Neutralization of interleukin 12 (IL-12) or gamma interferon in resistant mice resulted in decreased chemokine expression, while administration of IL-12 to susceptible mice resulted in an increase in the level of chemokine gene expression.

Indexed as

Gene Expression RegulationAnimalsBacterial ProteinsChemokine CXCL10ChemokinesChemokines, CXCInterferon-gammaInterleukin-12Leishmania majorLeishmaniasis, CutaneousMembrane ProteinsMiceMice, Inbred BALB CMice, Inbred C3HBacterial ProteinsChemokine CXCL10ChemokinesChemokines, CXCInterferon-gammaInterleukin-12Membrane Proteins

Identifiers

PMID12595483
PMCPMC148858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.